Haurwitz Rachel E. 4
4 · Caribou Biosciences, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Haurwitz Rachel E.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-03-14$1.02/sh+20,000$20,400→ 3,369,395 total(indirect: By Trust)
Holdings
- 295,450
Common Stock
Footnotes (2)
- [F1]This transaction was executed in multiple trades on 3/14/2025 at prices ranging from $1.00 to $1.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the specified range.
- [F2]Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse.